Home  >  News
News
  Daiichi Sankyo seeks Japanese health ministry nod for quizartinib,   October 17, 2018
  CIVCO Radiotherapy receives US & EU marketing approvals for Solstice SRS Immobilization System,   October 17, 2018
  Dr Reddy's launches generic Welchol in US market,   October 10, 2018
  Zydus receives US FDA marketing approval for generic Aromasin tablets,   October 05, 2018
  Ampere Medical to distribute Nexstim's SmartFocus TMS system in Hong Kong,   October 05, 2018
  Dr Reddy's Labs launches generic Gleevec tablets in US market,   October 01, 2018
  Endo Pharma recalls two lots of Robaxin 750mg tablets 100 count bottle pack due to labelling error,   October 01, 2018
  Zydus Cadila's desoximetasone cream receives US FDA marketing approval,   October 01, 2018
  Dova, Salix ink pact to co-promote Doptelet in US market,   September 29, 2018
  Sonoma Pharma licenses antimicrobial hypochlorous acid eye solution for management of blepharitis in Spanish/Portuguese markets to Brill Pharma,   September 28, 2018
  Ferring Pharma introduces Testavan in UK market to treat adult male hypogonadism,   September 26, 2018
  Gilead's subsidiary, Asegua Therapeutics to introduce generic Epclusa & Harvoni in US market to treat chronic hepatitis C,   September 26, 2018
  Amgen's Blincyto receives Japanese marketing approval to treat relapsed/refractory B-cell ALL,   September 26, 2018
  EMA committee recommends marketing approval for Bayer's haemophilia A drug, BAY94-9027,   September 25, 2018
  Mylan introduces generic Ampyra in US market,   September 24, 2018
  EMA committee recommends marketing approval for Eli Lilly's migraine drug, Emgality,   September 24, 2018
  EU grants marketing approval for Mylan & Fujifilm Kyowa Kirin Biologics' Hulio,   September 22, 2018
  EMA committee recommends marketing approval for Merck's HIV-1 medicines Delstrigo & Pifeltro,   September 22, 2018
  GeNeuro regains worldwide rights ex US & Japan to GNbAC1 in MS from Servier,   September 19, 2018
  Samumed, United Therapeutics ink North American licensing pact for idiopathic pulmonary fibrosis drug, SM04646,   September 18, 2018

 Back
 
ipc_2018
cphi-india_Banner-150x60
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |